NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-217-2005-2-EP-04 Human Monoclonal Antibodies That Specifically Bind IGF-II
00371041
00371041
00371041
00371041 		EP National Stage 06789775.1 Abandoned
NCI E-217-2005-2-AU-02 Human Monoclonal Antibodies That Specifically Bind IGF-II. AU National Stage 2006279633 Abandoned
NCI E-238-2005-0-PCT-02 Topical Formulation of Histone Deacetylase Inhibitors and Methods of Using the Same PCT PCT PCT/US2006/031870 Expired
NCI E-217-2005-2-PCT-01 Human Monoclonal Antibodies That Specifically Bind IGF-II PCT PCT COMB PCT/US2006/031814 Expired
NCI E-238-2005-0-JP-06 Topical Formulation of Histone Deacetylase Inhibitors and Methods of Using the Same JP National Stage 527070/2008 Abandoned
NCI E-238-2005-0-EP-05 Topical Formulation of Histone Deacetylase Inhibitors and Methods of Using the Same EP National Stage 06813470.9 Abandoned
NCI E-238-2005-0-AU-03 Topical Formulation of Histone Deacetylase Inhibitors and Methods of Using the Same AU National Stage 2006283677 Abandoned
NCI E-238-2005-0-CA-04 Topical Formulations of Histone Deacetylase Inhibitors and Methods of Using the Same CA National Stage 2619568 Abandoned
NIAID E-139-2006-0-US-01 Development Of Dengue Virus Vaccine Components US 60/837,723 Expired
NIMH E-294-2005-1-CA-03 Neuronal Avalanche Assay CA National Stage 2618933 Abandoned
NIMH E-294-2005-1-AU-07 Neuronal Avalanche Assay AU DIV 2013201187 Abandoned
NIMH E-294-2005-1-JP-06 Neuronal Avalanche Assay JP National Stage 2008-526298 Abandoned
NIMH E-294-2005-1-US-02 Neuronal Avalanche Assay US National Stage 11/990,419 8548786 Issued PDF
NCI E-007-2004-0-US-06 PYRROLOBENZODIAZEPINE DERIVATIVES, COMPOSITIONS COMPRISING THE SAME AND METHODS RELATED THERETO US National Stage 10/576,689 7511032 Abandoned PDF
NIMH E-294-2005-1-PCT-01 Neuronal Avalanche Assay PCT PCT COMB PCT/US2006/031884 Expired
NIMH E-294-2005-1-EP-05 Neuronal Avalanche Assay EP National Stage 06813476.6 Abandoned
NIMH E-294-2005-1-AU-04 Neuronal Avalanche Assay AU National Stage 2006279572 Abandoned
NCI E-275-2005-1-EP-05 Broad Spectrum Antibacterial Compounds EP National Stage 06851682.2 Issued
NCI E-275-2005-1-CA-04 Broad Spectrum Antibacterial Compounds CA National Stage 2617123 Abandoned
NCI E-275-2005-1-US-02 Broad-Spectrum Antibacterial Compounds US ORD 11/464,001 8691859 Abandoned PDF
NCI E-275-2005-1-US-03 Small Molecule Inhibitors of Botulinum Neurotoxins US ORD 11/464,007 7825154 Abandoned PDF
NIAID E-095-2000-0-AU-07 IDENTIFICATION OF A NOVEL DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION. AU DIV 2006203490 Expired
NCI E-275-2005-1-PCT-01 Broad Spectrum Antibacterial Compounds PCT PCT COMB PCT/US2006/031550 Expired
NIMH E-181-2005-2-PCT-01 Neuregulin1- Stimulated Cell Adhesion And Cell Migration PCT PCT COMB PCT/US2006/031217 Abandoned
NICHD E-304-2005-0-US-01 METHODS FOR TREATMENT AND DIAGNOSIS OF PSYCHIATRIC DISORDERS US 60/837,449 Abandoned
NEI E-110-2005-1-US-01 USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE US 60/837,312 Abandoned
NCI E-258-2005-0-AU-03 Method for Determining Redox Status of a Tissue AU National Stage 2006279951 Abandoned
NCI E-075-2003-0-US-03 Use Of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof US National Stage 10/574,645 Abandoned
NCI E-258-2005-0-EP-05 Method for Determining Redox Status of a Tissue EP National Stage 06789664.7 Abandoned
NCI E-258-2005-0-CA-04 Method for Determining Redox Status of a Tissue CA National Stage 2617962 Abandoned
NIA E-205-2006-0-US-01 Preparation Of R,R-Fenoterol And R,R-fenoterol Analogues And Their Use In Congestive Heart Failure US 60/837,161 Abandoned
NCI E-258-2005-0-PCT-02 Method for Determining Redox Status of a Tissue PCT PCT PCT/US06/031208 Expired
NEI E-008-2004-0-US-02 THERAPEUTIC ADMINISTRATION OF THE SCRAMBLED ANTI-ANGIOGENIC PEPTIDE C16Y US National Stage 10/588,884 8039585 Abandoned PDF
NIAID E-019-2007-0-US-01 Influenza Hemagglutinin and Neuraminidase Variants US 60/821,832 Abandoned
NHLBI E-120-2003-1-US-05 Method of Inducing Memory B Cell Development and Terminal Differentiation US National Stage 10/579,988 7993919 Abandoned PDF
NIDDK E-176-1999-0-US-07 Methanocarba Cycloalkyl Nucleoside Analogues US DIV 11/500,860 7790735 Expired PDF
NICHD E-016-1996-0-US-26 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS US CON 11/500,627 7759330 Expired PDF
NHLBI E-257-2005-0-US-01 Wide-area Fluorescence Detection System For Two-photon Microscopy US 60/835,462 Abandoned
NHLBI E-218-2006-0-US-01 TRIARYLMETHANE MATERIALS AND METHODS US 60/835,069 Abandoned
NCI E-052-2002-0-US-04 COMPOSITIONS AND METHODS FOR INHIBITING CELL GROWTH AND MODULATING GENE EXPRESSION US DIV 11/497,627 Abandoned
NIDDK E-165-1999-0-US-04 Potentiation of Antineoplastic Agents Using Sigma-2 Ligands US CON 11/497,945 Abandoned
NINDS E-261-2004-0-US-03 Peptidic Compound Mixtures As Therapeutic Agents In CNS Autoimmunity US National Stage 10/587,987 Abandoned
NCI E-035-1994-2-JP-17 ISOLATION OF CELLULAR MATERIAL UNDER MICROSCOPIC VISUALIZATION JP DIV 2006-208752 Abandoned
NIEHS E-103-2000-3-US-01 Biologically Potent Analogues of the DMT-TIC Pharmacophore and Methods of Use US 60/834,438 Abandoned
NCI E-211-2005-0-EP-05 Use Of Chk2 Kinase Inhibitors For Cancer Treatment EP National Stage 06800452.2 Abandoned
NCI E-211-2005-0-DE-07 Use Of Chk2 Kinase Inhibitors For Cancer Treatment DE EP 06800452.2 Abandoned
NCI E-211-2005-0-FR-08 Use Of Chk2 Kinase Inhibitors For Cancer Treatment FR EP 06800452.2 Abandoned
NCI E-211-2005-0-GB-09 Use Of Chk2 Kinase Inhibitors For Cancer Treatment GB EP 06800452.2 Abandoned
NCI E-211-2005-0-AU-03 Use Of Chk2 Kinase Inhibitors For Cancer Treatment AU National Stage 2006275679 Abandoned
NIDDK E-167-2005-0-PCT-02 Detecting and Characterizing Macromolecular Interactions in a Solution with a Simultaneous Measurement of Light Scattering and Concentration PCT PCT PCT/US2006/029413 Abandoned